Evidence map›Paper›PMID 34385995›Full record

ArticleFrontiers in microbiology2021

Pathogenic Characterization of

Ai Suzaki, Kaori Ohtani, Shihoko Komine-Aizawa, Asami Matsumoto, Shigeru Kamiya, Satoshi Hayakawa

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Microorganisms · 2024
    Review
  6. Article
  7. Review
  8. Mortality risk factors and fulminant sub-phenotype in anaerobic bacteremia: a 10-year retrospective, multicenter, observational cohort study.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2024
    Observational
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Severe Intravascular Hemolysis fromInfection and drug resistance · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Ai SuzakiDivision of Microbiology, Department of Pathology and Microbiology, Nihon University School of Medicine, Tokyo, Japan.
Kaori OhtaniDivision of Host Defense Mechanism, Department of Bacteriology and Bacterial Infection, Tokai University School of Medicine, Isehara, Japan.
Shihoko Komine-AizawaDivision of Microbiology, Department of Pathology and Microbiology, Nihon University School of Medicine, Tokyo, Japan.
Asami MatsumotoR&D Division, Miyarisan Pharmaceutical Co., LTD., Saitama, Japan.
Shigeru KamiyaR&D Division, Miyarisan Pharmaceutical Co., LTD., Saitama, Japan.
Satoshi HayakawaDivision of Microbiology, Department of Pathology and Microbiology, Nihon University School of Medicine, Tokyo, Japan.
Nihon University · JPKyorin University · JPTokai University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sepsis caused by

Indexed as

Clostridium perfringenscytokinehemolysisperfringolysin Ophospholipase Csepsis

Identifiers

PMID34385995
PMCPMC8353389
OpenAlexW3184088102

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.